亚宝药业：出售子公司62%股权完成工商变更登记

Core Viewpoint - The company announced the sale of a 62% stake in its subsidiary Taiyuan Pharmaceutical for a transfer price of 87.1887 million yuan, with the buyer being Shanxi Tongxiang Times Technology Co., Ltd. [1] Group 1 - The meeting to approve the sale was held on November 17, 2025 [1] - The completion of the share transfer registration was finalized on December 19 [1] - Post-transfer, the company retains a 5% stake in Taiyuan Pharmaceutical, which will no longer be included in the consolidated financial statements [1]